S
12.42
0.49 (4.11%)
| Penutupan Terdahulu | 11.93 |
| Buka | 11.74 |
| Jumlah Dagangan | 3,915,301 |
| Purata Dagangan (3B) | 6,466,135 |
| Modal Pasaran | 2,508,165,632 |
| Harga / Jualan (P/S) | 26.90 |
| Harga / Buku (P/B) | 16.87 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Nov 2026 |
| EPS Cair (TTM) | -0.360 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.13% |
| Nisbah Semasa (MRQ) | 4.64 |
| Aliran Tunai Operasi (OCF TTM) | -33.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -23.98 M |
| Pulangan Atas Aset (ROA TTM) | -58.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -144.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | SELLAS Life Sciences Group, Inc | Bercampur | Bercampur |
AISkor Stockmoo
-1.7
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -1.67 |
|
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.34% |
| % Dimiliki oleh Institusi | 14.34% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Anson Funds Management Lp | 30 Jun 2026 | 4,500,000 |
| Dagco, Inc. | 30 Jun 2026 | 1,232,433 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |